Confined or spread disease-Confined to the prostate gland - Page 5 of 13 Posts on Medivizor
Navigation Menu

Confined or spread disease-Confined to the prostate gland Posts on Medivizor

Can men with low-risk prostate cancer on active surveillance be monitored only by PSA and MRI?

Can men with low-risk prostate cancer on active surveillance be monitored only by PSA and MRI?

Posted by on Sep 7, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate if MRI scans (a test that takes detailed images of inside the body) could safely replace biopsies (samples taken from tissues for close examination) in active surveillance for prostate cancer. This study found that men with low-risk disease can be monitored using MRI and PSA levels with selective...

Read More

PSA response after cabazitaxel treatment is associated with improved progression-free survival in men with metastatic castration-resistant prostate cancer.

PSA response after cabazitaxel treatment is associated with improved progression-free survival in men with metastatic castration-resistant prostate cancer.

Posted by on Jan 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to examine the links between prostate specific antigen (PSA, a protein present in prostate cancer) and survival in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. This studty concluded that PSA response after cabazitaxel treatment is associated with improved...

Read More

Partial gland ablation versus prostate surgery in men with low- or intermediate-risk prostate cancer

Partial gland ablation versus prostate surgery in men with low- or intermediate-risk prostate cancer

Posted by on Nov 20, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine patient outcomes following partial gland ablation compared to robot-assisted radical prostate surgery in men with low- and intermediate- risk prostate cancer. The authors concluded that men with cancer confined to the prostate benefited from partial gland ablation, as it was more successful with fewer side...

Read More

Minor impact of watchful waiting and active surveillance of localized prostate cancer on psychological well-being and quality of life.

Minor impact of watchful waiting and active surveillance of localized prostate cancer on psychological well-being and quality of life.

Posted by on Nov 8, 2017 in Prostate cancer | 0 comments

In a nutshell This study investigated the impact monitoring an early stage prostate cancer had on quality of life or psychological state of mind. The study found that active surveillance or watchful waiting, instead of active treatment, has a minor impact on psychological and quality of life outcomes in the long-term. Some background Active...

Read More

The effect of yoga in men with prostate cancer receiving radiation therapy

Posted by on Sep 10, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effects of yoga on fatigue, erectile dysfunction, urinary problems and quality of life (QoL) in men undergoing radiation therapy for prostate cancer. The authors concluded that yoga twice-weekly during external beam radiation therapy (EBRT) significantly reduced pre-existing and radiation-related...

Read More

Hypofractionated compared to conventional radiation in prostate cancer patients

Posted by on Sep 4, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the efficacy and safety of hypofractionated radiation therapy compared to conventional radiation therapy in men with localised prostate cancer. The authors concluded that hypofractionated therapy was beneficial to men with localised prostate cancer, without enhancing side effects, in comparison to...

Read More

The timing of first biopsy and its effect on prostate cancer reclassification

The timing of first biopsy and its effect on prostate cancer reclassification

Posted by on Apr 3, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the influence of biopsy timing on prostate cancer reclassification during active surveillance.  The authors concluded that the timing of the first biopsy was not related to an increased risk of cancer reclassification, but prostate specific antigen (PSA) and body mass index (BMI – measured based...

Read More